SCHEMBL6777339

SCHEMBL6777339

COc1cccc(-n2nc(C(C)C)c3c2CC(C(C)C)CC3=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MGLL Q99685 1/20 0.39
DHODH Q02127 1/20 0.38
MAPT P10636 4/20 0.37
RAB9A P51151 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
KMT2A Q03164 3/20 0.37
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
SRC P12931 1/20 0.37
GSK3B P49841 1/20 0.36
S1PR4 O95977 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
S1PR1 P21453 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770505 0.89 OPRM1 (0.46) CASP1CASP7HSD17B10MGLLDHODH
SCHEMBL6775862 0.88 ABCG2 (0.39) CASP1CASP7HSD17B10MGLLMAPT
SCHEMBL6767259 0.87 SRC (0.40) MGLLDHODHMAPTSMN1; SMN2KMT2A
SCHEMBL6770575 0.86 GPBAR1 (0.39) CASP1CASP7HSD17B10MGLLDHODH
SCHEMBL6766674 0.85 RIPK2 (0.46) CASP1CASP7HSD17B10MGLLDHODH
SCHEMBL6164547 0.85 DHODH (0.43) DHODHSMN1; SMN2KMT2AMEN1ALDH1A1
SCHEMBL6772551 0.84 DHODH (0.37) CASP1CASP7HSD17B10MGLLDHODH
SCHEMBL6766574 0.83 ALDH1A1 (0.39) HSD17B10MGLLDHODHMAPTRAB9A
SCHEMBL6771294 0.81 SRC (0.49) MGLLMAPTRAB9ASMN1; SMN2KMT2A
SCHEMBL6770636 0.80 RIPK2 (0.35) CASP1CASP7HSD17B10MGLLDHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed
EP-1177185-A1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.p.A. (IT) 2002-02-06 EP disclosed
WO-2000069846-A1 4,5,6,7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA & UPJOHN S.P.A. (IT) 2000-11-23 WO disclosed